Daljeet Kohli’s experience with Ajanta Pharma and Shilpa Medicare shows that it is not...
Arjun
When we come across a seriously attractive investment opportunity, we must not get into...
PN Vijay’s brilliant stock picking has led to mega gains for him and his...
Two ace stock pickers, Prof. Sanjay Bakshi & Kenneth Andrade of IDFC MF, have...
Rakesh Jhunjhunwala says we should avoid much fancied stocks quoting at high valuations and...
Shilpa Medicare’s spectacular jump of 17% today is not an isolated instance. Most of...
Prof. Sanjay Bakshi is a staunch believer in the philosophy that you must not...
Rakesh Jhunjhunwala joins the long list of luminaries expressing concern over the exorbitant valuations...
In June 2014, IIFL issued a report identifying 13 top-quality mid-caps and urging investors...
When Rahul Saraogi of Atyant Capital and Ashish Kacholia are bullish on a stock,...
